赫西丁在任何度下都不能有效预防与呼吸机相关的肺炎:系统性审查和网络元分析
Alessandro De Cassai1, Tommaso Pettenuzzo2, Veronica Busetto3
1Sant'Antonio Anesthesia and Intensive Care Unit, University Hospital of Padua, Padua, Italy. alessandro.decassai@gmail.com.
口服赫西丁在重症监护病房患者中不能预防呼吸机相关的肺炎 (VAP). 这次元分析没有发现VAP预防或降低死亡率的显著益处,质疑其常规使用.
科学领域:
- 关键护理医学 关键护理医学
- 预防传染病 预防传染病
- 药理学 药理学是指药理学的学科.
背景情况:
- 呼吸机相关肺炎 (VAP) 是重症监护室的一个重大问题.
- 口服赫西丁通常用于VAP预防,但证据不一致.
- 本研究探讨了不同度的赫西丁在VAP预防中的有效性.
研究的目的:
- 评估口服赫西丁在机械通风ICU患者中预防VAP的有效性.
- 为了分析不同度的赫西丁用于VAP预防.
- 评估对死亡率和逗留时间等次要结果的影响.
主要方法:
- 随机对照试验 (RCT) 的网络元分析.
- 包括入侵性机械通风的成年ICU患者.
- 与安慰剂,假药或常规护理相比,比较了各种赫西丁度.
主要成果:
- 与对照组相比,赫西丁在预防VAP方面没有显著的优势.
- 没有观察到死亡率,机械通风持续时间或ICU停留时间的显著减少.
- 这些发现在不同分析中是一致的.
结论:
- 常规的口服赫西丁净化不推用于预防严重病情的成年患者的VAP.
- 目前的证据不支持用于VAP预防的赫西丁的使用.
- 可能需要进一步的研究来澄清任何潜在的利基应用.
更多相关视频
04:32Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
相关概念视频
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Hand hygiene
Hand washing...
Depolarizing Blockers: Pharmocokinetics
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Tracheostomy Decannulation
Description of the Procedure
Decannulation refers to the permanent removal of the tracheostomy tube, signaling the resolution of the condition that initially necessitated the tracheostomy. The process requires a well-coordinated interplay between...
Antimicrobial Effectiveness
